Cargando…
Effects of dasatinib on CD8(+)T, Th1, and Treg cells in patients with chronic myeloid leukemia
OBJECTIVE: To investigate the immunomodulatory effects of the tyrosine kinase inhibitor (TKI) dasatinib on T-cell subtypes in patients with chronic myeloid leukemia (CML). METHODS: T helper (Th) 1, Th2, regulatory T (Treg), and CD8(+)T cell levels were detected in patients with CML (n = 9) before an...
Autores principales: | Wei, Xiaoqing, He, Lin, Wang, Xiaodong, Lin, Min, Dai, Jingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607186/ https://www.ncbi.nlm.nih.gov/pubmed/31578901 http://dx.doi.org/10.1177/0300060519877321 |
Ejemplares similares
-
Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis
por: Raghuwanshi, Babita, et al.
Publicado: (2020) -
Precursor Lymphoblastic Lymphoma in the Extramedullary Tissue: A Rare Manifestation of Chronic Myeloid Leukemia in Blast Crisis
por: Mansoori, Huma, et al.
Publicado: (2020) -
Coexistence of Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia
por: Milosevic, Ivana
Publicado: (2016) -
Chronic myeloid leukemia with extreme thrombocytosis
por: Kim, So Young, et al.
Publicado: (2012) -
Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia
por: Zhang, Qianying, et al.
Publicado: (2017)